Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective

Abstract

Mean incremental direct treatment costs for Medicare beneficiaries with AF were higher than previously reported. Interventions that can reduce the incidence of AF and its complications may also reduce the national economic impact of AF.